144 related articles for article (PubMed ID: 33222309)
1. Tumor-only sequencing for oncology management: Germline-focused analysis and implications.
George A; Turnbull C
Genes Chromosomes Cancer; 2021 May; 60(5):352-357. PubMed ID: 33222309
[TBL] [Abstract][Full Text] [Related]
2. Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group.
Mandelker D; Donoghue M; Talukdar S; Bandlamudi C; Srinivasan P; Vivek M; Jezdic S; Hanson H; Snape K; Kulkarni A; Hawkes L; Douillard JY; Wallace SE; Rial-Sebbag E; Meric-Bersntam F; George A; Chubb D; Loveday C; Ladanyi M; Berger MF; Taylor BS; Turnbull C
Ann Oncol; 2019 Aug; 30(8):1221-1231. PubMed ID: 31050713
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutation panels: Time to clear their names.
Trottier AM; Cavalcante de Andrade Silva M; Li Z; Godley LA
Cancer Genet; 2019 Jun; 235-236():84-92. PubMed ID: 31101556
[TBL] [Abstract][Full Text] [Related]
4. Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis.
Batalini F; Peacock EG; Stobie L; Robertson A; Garber J; Weitzel JN; Tung NM
Breast Cancer Res; 2019 Sep; 21(1):107. PubMed ID: 31533767
[TBL] [Abstract][Full Text] [Related]
5. Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
Mandelker D; Zhang L; Kemel Y; Stadler ZK; Joseph V; Zehir A; Pradhan N; Arnold A; Walsh MF; Li Y; Balakrishnan AR; Syed A; Prasad M; Nafa K; Carlo MI; Cadoo KA; Sheehan M; Fleischut MH; Salo-Mullen E; Trottier M; Lipkin SM; Lincoln A; Mukherjee S; Ravichandran V; Cambria R; Galle J; Abida W; Arcila ME; Benayed R; Shah R; Yu K; Bajorin DF; Coleman JA; Leach SD; Lowery MA; Garcia-Aguilar J; Kantoff PW; Sawyers CL; Dickler MN; Saltz L; Motzer RJ; O'Reilly EM; Scher HI; Baselga J; Klimstra DS; Solit DB; Hyman DM; Berger MF; Ladanyi M; Robson ME; Offit K
JAMA; 2017 Sep; 318(9):825-835. PubMed ID: 28873162
[TBL] [Abstract][Full Text] [Related]
6. Practice Implications of Expanded Genetic Testing in Oncology.
Korngiebel DM; Zech JM; Chappelle A; Burke W; Carline JD; Gallagher TH; Fullerton SM
Cancer Invest; 2019; 37(1):39-45. PubMed ID: 30676118
[TBL] [Abstract][Full Text] [Related]
7. A Case-Based Approach to Understanding Complex Genetic Information in an Evolving Landscape.
DiNardo CD; Korde LA; Yurgelun MB
Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-11. PubMed ID: 34010053
[TBL] [Abstract][Full Text] [Related]
8. Use of Treatment-Focused Tumor Sequencing to Screen for Germline Cancer Predisposition.
Lau TTY; May CM; Sefid Dashti ZJ; Swanson L; Starks ER; Parker JDK; Moore RA; Tucker T; Bosdet I; Young SS; Santos JL; Compton K; Heidary N; Hoang L; Schrader KA; Sun S; Kwon JS; Tinker AV; Karsan A
J Mol Diagn; 2021 Sep; 23(9):1145-1158. PubMed ID: 34197922
[TBL] [Abstract][Full Text] [Related]
9. Germline potential should not be overlooked for cancer variants identified in tumour-only somatic mutation testing.
Al-Shinnag M; Cheong PL; Goodwin A; Trent R; Yu B
Pathology; 2024 Jun; 56(4):468-472. PubMed ID: 38627125
[TBL] [Abstract][Full Text] [Related]
10. Germline, hematopoietic, mosaic, and somatic variation: interplay between inherited and acquired genetic alterations in disease assessment.
Konnick EQ; Pritchard CC
Genome Med; 2016 Oct; 8(1):100. PubMed ID: 27716394
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of custom-designed NGS panel testing in pediatric tumors.
Surrey LF; MacFarland SP; Chang F; Cao K; Rathi KS; Akgumus GT; Gallo D; Lin F; Gleason A; Raman P; Aplenc R; Bagatell R; Minturn J; Mosse Y; Santi M; Tasian SK; Waanders AJ; Sarmady M; Maris JM; Hunger SP; Li MM
Genome Med; 2019 May; 11(1):32. PubMed ID: 31133068
[TBL] [Abstract][Full Text] [Related]
12. Post-mortem testing; germline BRCA1/2 variant detection using archival FFPE non-tumor tissue. A new paradigm in genetic counseling.
Petersen AH; Aagaard MM; Nielsen HR; Steffensen KD; Waldstrøm M; Bojesen A
Eur J Hum Genet; 2016 Aug; 24(8):1104-11. PubMed ID: 26733283
[TBL] [Abstract][Full Text] [Related]
13. Pitfalls in variant annotation for hereditary cancer diagnostics: The example of Illumina® VariantStudio®.
Kalfakakou D; Konstantopoulou I; Yannoukakos D; Fostira F
Genomics; 2021 Jan; 113(1 Pt 2):748-754. PubMed ID: 33053411
[TBL] [Abstract][Full Text] [Related]
14. Toward Concurrent Testing for Somatic and Germline Variants in Cancer Patients.
Mandelker D
Clin Cancer Res; 2016 Aug; 22(16):3987-8. PubMed ID: 27307597
[TBL] [Abstract][Full Text] [Related]
15. The role of genomic profiling in adolescents and young adults (AYAs) with advanced cancer participating in phase I clinical trials.
McVeigh TP; Sundar R; Diamantis N; Kaye SB; Banerji U; Lopez JS; de Bono J; van der Graaf WTA; George AJ
Eur J Cancer; 2018 May; 95():20-29. PubMed ID: 29614442
[TBL] [Abstract][Full Text] [Related]
16. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Based Genetic Testing and Familial Cancer Risk.
Forman A; Sotelo J
Cold Spring Harb Perspect Med; 2020 Aug; 10(8):. PubMed ID: 31570381
[TBL] [Abstract][Full Text] [Related]
18. When Should Tumor Genomic Profiling Prompt Consideration of Germline Testing?
DeLeonardis K; Hogan L; Cannistra SA; Rangachari D; Tung N
J Oncol Pract; 2019 Sep; 15(9):465-473. PubMed ID: 31509718
[TBL] [Abstract][Full Text] [Related]
19. "Somatic" Tumor Genomic Profiling and Potential Germline Implications: Ethical Considerations for Children with Cancer.
Knapp E
J Law Med Ethics; 2020 Dec; 48(4):778-783. PubMed ID: 33404327
[No Abstract] [Full Text] [Related]
20. Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing.
Terraf P; Pareja F; Brown DN; Ceyhan-Birsoy O; Misyura M; Rana S; O'Reilly E; Carlo MI; Aghajanian C; Liu Y; Derakhshan F; Jayakumaran G; Weigelt B; Walsh M; Stadler Z; Offit K; Ladanyi M; Robson M; Zehir A; Reis-Filho JS; Mandelker D
Ann Oncol; 2022 Apr; 33(4):426-433. PubMed ID: 35074424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]